An Official Journal of the Japan Primary Care Association
Online ISSN : 2187-2791
Print ISSN : 2185-2928
ISSN-L : 2185-2928
Current issue
Displaying 1-9 of 9 articles from this issue
  • Yotaro Arima, Takashi Watanabe, Yuzou Shitou, Kazuhiro Sumitomo, Kouji ...
    2024 Volume 47 Issue 2 Pages 34-42
    Published: June 20, 2024
    Released on J-STAGE: June 18, 2024

    Introduction: This study aimed to survey patients on polypharmacy regarding their own intention and inclination to reduce medication use, and their subjective understanding of drug effectiveness and side effects. We aimed to contribute to the establishment of an information base to address polypharmacy.

    Methods: We enrolled 100 adult patients who had been admitted and administered ≥ 5 oral medications. A questionnaire was utilized to assess their willingness and inclination to reduce their medications, as well as their subjective understanding of drug effectiveness and side effects.

    Results: Sixty-two patients expressed an intention to reduce their medication use, citing reasons including medication management, drug combinations, and side effects. The proportion of patients with this intention increased as the number of prescribed medications increased. Of the 38 individuals who responded that they had no intention of reducing their medication, 21 (55.3%) cited the reason as being that they received the prescription from a physician. The level of understanding about the effectiveness of their own medications was significantly lower among those aged ≥ 75 years. However, the level of understanding of side effects did not vary based on age or number of prescriptions.

    Conclusion: To promote the optimization of prescriptions, it is necessary to ascertain patients' intentions, and the relationship between patients and prescribing physicians.

    Download PDF (754K)
  • Takuya Aoki, Shintaro Kosaka, Sachiko Ozone, Keitaro Fukui
    2024 Volume 47 Issue 2 Pages 43-48
    Published: June 20, 2024
    Released on J-STAGE: June 18, 2024

    Introduction: The aim of this study was to investigate the current status of patient safety management systems in primary care clinics in Japan.

    Methods: An online survey on patient safety management systems was conducted among primary care physicians certified by the Japan Primary Care Association who serve as clinic managers.

    Results: A total of 183 physicians participated in the survey. We found that 53.0%, 73.2%, 38.8%, and 32.8% had developed medical safety guidelines, nosocomial infection control guidelines, drug safety guidelines, and medical device safety guidelines, respectively. Furthermore, 64.5% had fewer than 10 incident/accident reports in the past year, the most common of which were prescription errors, vaccine errors, falls, and needle sticks.

    Conclusion: The issues identified in this study serve as a basis for promoting the development of educational programs and the creation of evaluation and improvement tools aimed at enhancing patient safety in clinics.

    Download PDF (440K)
  • Rie Ono, Shin Takayama, Natsumi Saito, Ryutaro Arita, Akiko Kikuchi, K ...
    2024 Volume 47 Issue 2 Pages 49-55
    Published: June 20, 2024
    Released on J-STAGE: June 18, 2024

    Fatigue is a common symptom of long COVID. Fatigue can majorly disrupt daily life and be challenging to treat. Herein, we describe the effect of saikokeishito, a Kampo medicine, on fatigue in patients with long COVID.

    Between October 2020 and March 2023, we prescribed saikokeishito to 22 patients with long COVID in the general medicine outpatient department of our hospital. Among them, seven patients (age: 15-58 years, two females) had fatigue, a previously confirmed diagnosis of COVID-19, and no concomitant use of other Kampo formulas. We compared their condition at the start of saikokeishito administration to that 3 months later. Five patients had a slight fever, and four had inflammatory findings on blood tests. Within 3 months, all patients had a 20% or greater reduction in fatigue on a visual analogue scale. Six patients had a 20% or greater increase in health-related QOL and were able to return to society. On the other hand, one patient required a transition to an alternative medication, and one patient's follow-up was prematurely discontinued. Fatigue after COVID-19 may be improved by saikokeishito, especially for the treatment of patients with slight fever or inflammatory findings.

    Download PDF (397K)